Searched for
CLOPIDOGREL
IOL Chemicals shares surge 5% as board announces 1:5 stock splitIOL Chemicals share price: IOL Chemicals proposed stock split is subject to shareholder approval via a postal ballot. The record date to de...- IOL Chemicals announces 1:5 stock split; record date soonIOL Chemicals has approved a 1:5 stock split. This will increase affordability and liquidity. Shareholders will receive 5 new shares for ev...
- IOL Chemicals gets EDQM certification for API supply to EuropeThe European Directorate for the Quality of Medicines & HealthCare (EDQM) is a mandatory certification for distribution of any API/ pharma ...
- IOL to diversify its API and specialty chemicals portfolios to boost salesThe Ludhiana-based company generates about 30% of its ₹2,216 crore revenues from the commodity API ibuprofen, where it is vertically integr...
- Drug pricing regulator NPPA fixes retail prices of 84 drug formulationsSimilarly, the price of Paracetamol and Caffeine has been fixed at Rs 2.88 per tablet. Besides, the price of one Rosuvastatin Aspirin and C...
- Brokerages raise target prices on Dr Reddy’s after strong Q3Credit Suisse has maintained outperform rating with a target price of Rs 3,235.
- Key diabetes, anti-cancer drugs among 92 in price-ceiling listThe National Pharmaceutical Pricing Authority said in orders dated August 13 that manufacturers of these drugs will fix their retail prices...
- NPPA fixes prices of 22 drug formulationsWhile National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 20 formulations, it has also capped the ceiling prices of...
- NPPA fixes retail prices of 14 formulationsDrug price regulator has also asked manufacturers to furnish quarterly return regarding production, import and sale of their products.
- Dr Reddy's Laboratories to expand capacity of manufacturing units in TelanganaDr Reddy's Laboratories is set to expand the capacity of three of its bulk drugs and intermediates manufacturing plants located in Telangan...
- Wockhardt gets USFDA nod for tablets to check heart attackDrug firm Wockhardt said it has received USFDA approval to market clopidogrel bisulfate tablets used for reducing risk of heart attack.
- Why Dr Reddy's labs is going to report good resultsThe Hyderabad-based company with FY12 net sales Rs 9674 crore is expected to report good results to the cheer of its investors.
- Dr Reddy's Laboratories, Mylan launch Clopidogrel tablets in US marketDr Reddy's Laboratories announced today that it has launched Clopidogrel tablets, USP, a bioequivalent generic version of Plavix in the US ...
- Dr Reddy's, Sun Pharma get USFDA nod for heart disease drugDr Reddy's said it has launched clopidogrel tablets in the American market today after receiving approval from the US Food and Drug Adminis...
- RPG Life looks abroad for marketing tie-upsRPG Life Sciences is eyeing marketing and distribution tie-ups with foreign companies, a top company official said.
- RPG Life Sciences eyeing overseas tie-ups to push its productsWith a view to push its bulk drugs and immuno-suppressant products overseas, RPG Life Sciences is eyeing marketing and distribution tie-ups...
- ‘EU to resolve drugs seizure issue soon’EU trade commissioner said it will soon resolve the issue of confiscation of Indian drugs being exported to developing countries.
- NPPA fixes prices of formulation of AtorvastatinDrug price regulator, National Pharmaceutical Pricing Authority (NPPA) on Monday fixed the price of formulation of Atorvastatin, Clopidogre...
- Dr Reddy's may land a major role in Plavix patent playWith the block-the-sale request filed by Bristol-Myers Squibb (BMS) and partner Sanofi-Aventis against Apotex’s brazen launch of generic ‘P...
- A twist in the patent taleGeneric drugmaker has stunned the pharma world by coming out with a generic version of Plavix,.
Load More
